Victory Capital Management Inc. Trims Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)

Victory Capital Management Inc. trimmed its holdings in Semler Scientific, Inc. (NASDAQ:SMLR) by 66.9% in the 4th quarter, Holdings Channel reports. The fund owned 6,386 shares of the company’s stock after selling 12,912 shares during the quarter. Victory Capital Management Inc.’s holdings in Semler Scientific were worth $345,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Principal Financial Group Inc. bought a new position in shares of Semler Scientific during the third quarter valued at approximately $361,000. GSA Capital Partners LLP grew its stake in shares of Semler Scientific by 73.9% in the 3rd quarter. GSA Capital Partners LLP now owns 10,336 shares of the company’s stock worth $243,000 after buying an additional 4,393 shares during the last quarter. Quest Partners LLC grew its stake in shares of Semler Scientific by 48.0% in the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after buying an additional 817 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in Semler Scientific by 9.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 43,823 shares of the company’s stock valued at $1,032,000 after buying an additional 3,925 shares in the last quarter. Finally, Cerity Partners LLC raised its stake in Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after buying an additional 642,982 shares during the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.

Semler Scientific Stock Performance

Shares of SMLR stock opened at $39.22 on Friday. The company has a market capitalization of $376.39 million, a price-to-earnings ratio of 7.99 and a beta of 1.33. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $81.56. The company’s 50-day moving average is $47.23 and its 200 day moving average is $44.21.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The firm had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Wall Street Analyst Weigh In

Separately, Lake Street Capital increased their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.